Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00264407 · ClinicalTrials.gov registry record
Neural Changes in the Aging Auditory System
A clinical trial of Hearing and Progesterone, sponsored by University of Rochester.
- Completed
- Registry status
- 126
- Enrollment target
- 2
- Study locations
NCT00264407 is a study of Hearing and Progesterone that has completed, run by University of Rochester. The registered enrollment target is 126 participants, below the 167,008-participant average among 3 other Hearing trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00264407, a study of Hearing and Progesterone, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study was to determine the effects of hormone replacement therapy (HRT) on hearing in post-menopausal women.
Conditions Studied
Interventions
- DRUG Hormone Replacement Therapy - HRT
Study Locations (2)
New York
- International Center Hearing & Speech Research - NTID - RIT - Rochester
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2001-01 |
| Est. Completion | 2005-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00264407
The ClinicalTrials.gov registry entry for NCT00264407 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167,008-participant average among 3 other Hearing trials with a reported enrollment target (100% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Hearing appearing as the primary indexed condition, and to 1 intervention - of which Hormone Replacement Therapy - HRT is the first listed.
NCT00264407 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00264407 about?
NCT00264407 is a clinical study titled "Neural Changes in the Aging Auditory System". The purpose of this study was to determine the effects of hormone replacement therapy (HRT) on hearing in post-menopausal women.
What is the current status of trial NCT00264407?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2001-01. Estimated completion is 2005-02.
What conditions does trial NCT00264407 study?
This clinical trial studies the following conditions: Hearing, Progesterone, Estrogens, Psychoacoustics, Auditory Perceptual Disorders.
What interventions are being tested in trial NCT00264407?
The interventions under investigation include: Hormone Replacement Therapy - HRT (DRUG).
Who is sponsoring clinical trial NCT00264407?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00264407 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.